Tarroza, Danilo B.

HRN: 29-14-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2026
CEFTRIAXONE 1G (VIAL)
06/10/2026
06/17/2026
IV
2G
OD
COMPLICATED UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: